TAQ1
MCID: TQP001
MIFTS: 35

Taqi Polymorphism (TAQ1)

Aliases & Classifications for Taqi Polymorphism

MalaCards integrated aliases for Taqi Polymorphism:

Name: Taqi Polymorphism 58
Taq1 58

External Ids:

OMIM 58 313480

Summaries for Taqi Polymorphism

MalaCards based summary : Taqi Polymorphism, also known as taq1, is related to impulse control disorder and heroin dependence. An important gene associated with Taqi Polymorphism is VDR (Vitamin D Receptor), and among its related pathways/superpathways is Development_Hedgehog and PTH signaling pathways in bone and cartilage development. The drugs Dopamine and Bupropion have been mentioned in the context of this disorder. Affiliated tissues include kidney, brain and endothelial, and related phenotypes are Increased LDL uptake and cardiovascular system

Description from OMIM: 313480

Related Diseases for Taqi Polymorphism

Diseases related to Taqi Polymorphism via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 53, show less)
# Related Disease Score Top Affiliating Genes
1 impulse control disorder 10.2 ANKK1 DRD2
2 heroin dependence 10.2 ANKK1 DRD2
3 alexithymia 10.2 ANKK1 DRD2
4 antisocial personality disorder 10.2 ANKK1 DRD2
5 arteries, anomalies of 10.1
6 multiple sclerosis 10.1
7 coronary artery anomaly 10.1
8 breast cancer 10.0
9 systemic lupus erythematosus 10.0
10 schizophrenia 10.0
11 lupus erythematosus 10.0
12 colorectal cancer 10.0
13 ataxia-telangiectasia 10.0
14 osteoarthritis 10.0
15 restless legs syndrome 10.0
16 telangiectasis 10.0
17 periodontal disease 10.0
18 idiopathic hypercalciuria 10.0 REN VDR
19 mineral metabolism disease 9.9 REN VDR
20 alcohol dependence 9.8
21 alzheimer disease 9.8
22 biliary cirrhosis, primary, 1 9.8
23 bladder cancer 9.8
24 attention deficit-hyperactivity disorder 9.8
25 hypercholesterolemia, familial 9.8
26 hypertension, essential 9.8
27 prostate cancer 9.8
28 rheumatoid arthritis 9.8
29 leprosy 3 9.8
30 periodontitis, chronic 9.8
31 aarskog-scott syndrome 9.8
32 muscular dystrophy, duchenne type 9.8
33 prostate cancer, hereditary, 8 9.8
34 dermatitis, atopic 9.8
35 prostate cancer, hereditary, 6 9.8
36 arthritis 9.8
37 diabetes mellitus 9.8
38 pol iii-related leukodystrophies 9.8
39 primary biliary cirrhosis 9.8
40 inflammatory bowel disease 9.8
41 lepromatous leprosy 9.8
42 melanoma 9.8
43 dermatitis 9.8
44 kidney disease 9.8
45 thyroid hyalinizing trabecular adenoma 9.8
46 periodontitis 9.8
47 psoriasis 9.8
48 cleft lip 9.8
49 muscular dystrophy 9.8
50 polycystic kidney disease 9.8
51 hansen's disease 9.8
52 primary biliary cholangitis 9.8
53 vesicoureteral reflux 1 9.6 REN UPK1B

Graphical network of the top 20 diseases related to Taqi Polymorphism:



Diseases related to Taqi Polymorphism

Symptoms & Phenotypes for Taqi Polymorphism

Clinical features from OMIM:

313480

GenomeRNAi Phenotypes related to Taqi Polymorphism according to GeneCards Suite gene sharing:

27 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased LDL uptake GR00340-A-1 8.62 LDLR UPK1B

MGI Mouse Phenotypes related to Taqi Polymorphism:

47 (showing 6, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.91 ACTA2 DRD2 FGA LDLR REN TGFA
2 digestive/alimentary MP:0005381 9.87 DRD2 FGA IL12B INHBA LDLR TGFA
3 hematopoietic system MP:0005397 9.86 CCNA2 DRD2 FGA IL12B INHBA LDLR
4 immune system MP:0005387 9.76 CCNA2 DRD2 FGA IL12B LDLR REN
5 integument MP:0010771 9.43 DRD2 FGA INHBA LDLR TGFA VDR
6 muscle MP:0005369 9.17 ACTA2 DRD2 INHBA LDLR REN TGFA

Drugs & Therapeutics for Taqi Polymorphism

Drugs for Taqi Polymorphism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 36, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4 62-31-7, 51-61-6 681
2
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
3 Raclopride Investigational Phase 4 84225-95-6
4 Cytochrome P-450 Enzyme Inhibitors Phase 4
5 Sympathomimetics Phase 4
6 Cardiotonic Agents Phase 4
7 Antidepressive Agents, Second-Generation Phase 4
8 Dopamine Uptake Inhibitors Phase 4
9 Neurotransmitter Agents Phase 4
10 Psychotropic Drugs Phase 4
11 Dopamine Agents Phase 4
12 Antidepressive Agents Phase 4
13 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
14 Neurotransmitter Uptake Inhibitors Phase 4
15 Peripheral Nervous System Agents Phase 4
16 Autonomic Agents Phase 4
17 Protective Agents Phase 4
18
Temozolomide Approved, Investigational Phase 1, Phase 2 85622-93-1 5394
19
Calcitriol Approved, Nutraceutical Phase 1, Phase 2 32222-06-3 5280453 134070
20
Calcium Approved, Nutraceutical Phase 1, Phase 2 7440-70-2 271
21 Vasoconstrictor Agents Phase 1, Phase 2
22 Trace Elements Phase 1, Phase 2
23 Nutrients Phase 1, Phase 2
24 Bone Density Conservation Agents Phase 1, Phase 2
25 Calcium, Dietary Phase 1, Phase 2
26 Alkylating Agents Phase 1, Phase 2
27 Vitamins Phase 1, Phase 2
28 Hormones Phase 1, Phase 2
29 Antineoplastic Agents, Alkylating Phase 1, Phase 2
30 Micronutrients Phase 1, Phase 2
31
Ergocalciferol Approved, Nutraceutical 50-14-6 5280793
32
Vitamin D Approved, Nutraceutical, Vet_approved 1406-16-2
33 Calciferol
34 Ergocalciferols
35 Vitamin D2
36 Dihydroxycholecalciferols

Interventional clinical trials:

(showing 8, show less)
# Name Status NCT ID Phase Drugs
1 PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration Completed NCT00846339 Phase 4 Bupropion
2 Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma Completed NCT00301067 Phase 1, Phase 2 Temozolomide
3 Brain-to-Society Diagnostic for Prevention of Childhood Obesity and Chronic Disease Unknown status NCT03151694
4 Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma Completed NCT02539745
5 Cognitive Processes Study in Obese Women With and Without Eating Disorders Completed NCT01948414 Not Applicable
6 Practice Based Nutrition Intervention-2 Completed NCT01700868 Not Applicable
7 RISSCI-1 Blood Cholesterol Response Study Recruiting NCT03270527 Not Applicable
8 Plant-Based Dietary Intervention in Type 2 Diabetes-2 Suspended NCT01931631 Not Applicable

Search NIH Clinical Center for Taqi Polymorphism

Genetic Tests for Taqi Polymorphism

Anatomical Context for Taqi Polymorphism

MalaCards organs/tissues related to Taqi Polymorphism:

42
Kidney, Brain, Endothelial, Smooth Muscle, Thyroid

Publications for Taqi Polymorphism

Articles related to Taqi Polymorphism:

(showing 111, show less)
# Title Authors Year
1
Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases. ( 30929318 )
2019
2
Vitamin D receptor gene polymorphisms (Apa1 and Taq1) in temporomandibular joint internal derangement/osteoarthritis in a group of Turkish patients. ( 30155592 )
2018
3
Vitamin D Receptor TaqI Polymorphism Is Associated With Reduced Follicle Number in Women Utilizing Assisted Reproductive Technologies. ( 29892263 )
2018
4
Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis. ( 29910622 )
2018
5
Association of dopamine receptor D2 gene (DRD2) Taq1 polymorphisms with eating behaviors and obesity among Chinese and Indian Malaysian university students. ( 29737821 )
2018
6
Association Study of Transforming Growth Factor Alpha TaqI Polymorphism and the Risk of Cleft Lip and/or Palate in an Iranian Population. ( 29105380 )
2017
7
Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis. ( 29072133 )
2017
8
ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population. ( 26275878 )
2016
9
Calcitonin Receptor AluI (rs1801197) and Taq1 Calcitonin Genes Polymorphism in 45-and Over 45-year-old Women and their Association with Bone Density. ( 27708484 )
2016
10
Influence of Apa1 (rs7975232), Taq1 (rs731236) and Bsm1 (rs154410) polymorphisms of vitamin D receptor on preterm birth risk in the Polish population. ( 27958635 )
2016
11
Association Between Vitamin D Receptor rs731236 (Taq1) Polymorphism and Risk for Restless Legs Syndrome in the Spanish Caucasian Population. ( 26632733 )
2015
12
The associations among the dopamine D2 receptor Taq1, emotional intelligence, creative potential measured by divergent thinking, and motivational state and these associations' sex differences. ( 26217259 )
2015
13
A novel TaqI polymorphism in the coding region of the ovine TNXB gene in the MHC class III region: morphostructural and physiological influences. ( 23877191 )
2014
14
TaqI polymorphism of VDR gene contributes to breast cancer risk. ( 23904261 )
2014
15
Association between circulating vitamin D, the Taq1 vitamin D receptor gene polymorphism and colorectal cancer risk among Jordanians. ( 25227839 )
2014
16
Association between periodontal disease and Interleukin-1β +3953 and vitamin D receptor Taq1 genetic polymorphisms in an Italian caucasian population. ( 23991270 )
2013
17
Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis. ( 23300018 )
2013
18
Vitamin D3 receptor ( VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. ( 23840333 )
2013
19
Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. ( 21816760 )
2012
20
Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report. ( 22051885 )
2012
21
Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. ( 21168462 )
2011
22
VDR TaqI polymorphism is associated with chronic periodontitis in Italian population. ( 21764034 )
2011
23
Parent-child concordance of Taq1 A1 allele predicts similarity of parent-child weight loss in behavioral family-based treatment programs. ( 20561550 )
2010
24
Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians. ( 22460205 )
2010
25
Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels. ( 21088715 )
2009
26
[Association between the TaqI polymorphism of the vitamin D receptor gene and lepromatous leprosy in a Mexican population sample]. ( 19180314 )
2009
27
Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population. ( 18426314 )
2008
28
Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population. ( 19056069 )
2008
29
Strong association of the renin TaqI polymorphism with essential hypertension in Chinese Han and Tibetan populations. ( 17476284 )
2007
30
DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers. ( 18058350 )
2007
31
Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. ( 16965356 )
2006
32
Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3. ( 16789008 )
2006
33
An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. ( 15939106 )
2005
34
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? ( 14668077 )
2003
35
A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. ( 12424624 )
2002
36
Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism. ( 11331109 )
2001
37
Nature of the fibrinogen Aalpha gene TaqI polymorphism. ( 11583334 )
2001
38
Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. ( 11894971 )
2001
39
Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol. ( 11353448 )
2001
40
Association analysis for dopamine D2 receptor Taq1 polymorphism with P300 event-related potential for normal young females. ( 11702060 )
2001
41
Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. ( 10948074 )
2000
42
The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients. ( 10862524 )
2000
43
No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study. ( 10898926 )
2000
44
Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients. ( 11131175 )
2000
45
A TaqI polymorphism in the chicken interferon regulatory factor 1 (IRF1) gene provides evidence that chicken linkage group E48C28W13 represents one of the microchromosomes. ( 10380694 )
1999
46
Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. ( 10405913 )
1999
47
The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. ( 10578241 )
1999
48
Lack of correlation of free deoxypyridinoline excretion with Taq1 restriction length polymorphisms in the vitamin D receptor gene in males. ( 9641356 )
1998
49
D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. ( 9672902 )
1998
50
Chromosomal localization of the human urothelial "tetraspan" gene, UPK1B, to 3q13.3-q21 and detection of a TaqI polymorphism. ( 9073521 )
1997
51
TaqI polymorphism in Oct-1 in chickens. ( 9124723 )
1997
52
TaqI polymorphism in the 3' flanking region of the PI gene among Kuwaiti Arabs and Russians. ( 9160183 )
1997
53
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. ( 9429233 )
1997
54
A high-frequency TaqI polymorphism at the ovine phenylalanine hydroxylase (PAH)locus. ( 8856909 )
1996
55
PCR detection of the Taq1 restriction fragment length polymorphism linked to the ataxia telangiectasia locus. ( 7720261 )
1995
56
A TaqI polymorphism in a gene belonging to the human apoprotein(a)-plasminogen gene family on the telomeric region of chromosome 6 (6q26-27). ( 7554370 )
1995
57
An intragenic TaqI polymorphism in the faciogenital dysplasia (FGD1) locus, the gene responsible for Aarskog syndrome. ( 7557980 )
1995
58
Association study of transforming growth factor alpha (TGF alpha) TaqI polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. ( 7702037 )
1995
59
A TaqI polymorphism in the human erythroid beta spectrin gene. ( 7868137 )
1995
60
A TaqI polymorphism at the porcine arachidonate 12-lipoxygenase (ALOX12) locus. ( 8572372 )
1995
61
A TaqI polymorphism in the bovine blood coagulation factor XIII a subunit gene. ( 7695131 )
1994
62
A compound TaqI polymorphism in sheep revealed by a carbonic anhydrase II (CA2) probe. ( 7818185 )
1994
63
A TaqI polymorphism at the beta-globin (HBB) locus in cattle. ( 7818188 )
1994
64
TaqI polymorphism of the human MXI1 gene. ( 7881441 )
1994
65
TaqI polymorphism of the human tissue inhibitor of metallo-proteinases-2 (Timp2) gene. ( 7909251 )
1994
66
TaqI polymorphism in intron 2 of the GCDH gene. ( 8069322 )
1994
67
A TaqI polymorphism at the immunoglobulin kappa light chain locus in Merino sheep. ( 8161025 )
1994
68
No effect of TaqI polymorphism at the human renal kallikrein (KLK1) locus on normal blood pressure level or variability. ( 7903227 )
1993
69
PA2.1 detects a TaqI polymorphism in the pseudoautosomal region. ( 8098984 )
1993
70
TaqI polymorphism in the human thyrotropin receptor gene (TSHR). ( 8102575 )
1993
71
The Y-specific p21A1/TaqI polymorphism occurs in four major population Oroups. ( 8514323 )
1993
72
TaqI polymorphism of the epidermal growth factor receptor gene in Caucasoids and Japanese. ( 8514325 )
1993
73
A new TaqI polymorphism in the p53 gene. ( 1347421 )
1992
74
A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. ( 1353022 )
1992
75
Identification of TaqI polymorphism in the mitochondrial acetoacetyl-CoA thiolase gene and familial analysis of 3-ketothiolase deficiency. ( 1362557 )
1992
76
A rare TaqI polymorphism in a human complement C4 gene is caused by an additional restriction site in the first intron. ( 1362564 )
1992
77
TaqI polymorphism at the alanine:glyoxylate aminotransferase (AGXT) gene locus. ( 1363874 )
1992
78
A TaqI polymorphism at the ovine beta A-inhibin (INHBA) locus. ( 1503266 )
1992
79
A TaqI polymorphism at the bovine locus for uridine monophosphate synthase (UMPS). ( 1570898 )
1992
80
No effect of a Taq1 polymorphism in DNA at the endothelin I (EDN1) locus on normal blood pressure level or variability. ( 1347490 )
1992
81
TaqI polymorphism at D5S205, located within 5q11.2-13.3. ( 1673556 )
1991
82
A TaqI polymorphism detected by a genomic clone at the locus D5S39 (5q11-13). ( 1674137 )
1991
83
A TaqI polymorphism adjacent to the factor VIII gene (F8C). ( 1675002 )
1991
84
A TaqI polymorphism in the human cyclin A gene. ( 1675006 )
1991
85
A TaqI polymorphism in the human NF1 gene. ( 1679535 )
1991
86
A TaqI polymorphism at the ovine alpha-inhibin locus. ( 1679979 )
1991
87
TaqI polymorphism at the human preproendothelin-1 gene (EDN1). ( 1681505 )
1991
88
New TaqI polymorphism in the RRM1 gene. ( 1682881 )
1991
89
PCR detection of a TaqI polymorphism at the CCAATT box of the human tyrosinase (TYR) gene. ( 1682887 )
1991
90
A new DNA marker, D3S742, identifies a MspI and a TaqI polymorphism on chromosome 3p. ( 1721707 )
1991
91
Detection of a TaqI polymorphism within the human TPA gene (PLAT). ( 1909437 )
1991
92
TaqI polymorphism in the 3' flanking region of the human aortic smooth muscle actin gene. ( 1969628 )
1990
93
TaqI polymorphism in the complement component C7 gene. ( 1970871 )
1990
94
A TaqI polymorphism identified by 26-6 (D16S125) proximal to the locus affecting adult polycystic kidney disease (PKD1) on chromosome 16. ( 1971930 )
1990
95
An anonymous DNA probe H35 (D9S41) on chromosome 9 detects a TaqI polymorphism. ( 1972567 )
1990
96
TaqI polymorphism at the human complement component C9 gene. ( 1977126 )
1990
97
A three allele TaqI polymorphism at TOP1 gene. ( 1977141 )
1990
98
TaqI polymorphism at the D6S91 locus. ( 1977146 )
1990
99
An anonymous DNA probe E20 [D4S143] on chromosome 4 detects a TaqI polymorphism. ( 2308867 )
1990
100
PCR detection of the TAQ1 polymorphism at the CA2 locus. ( 1977133 )
1990
101
TaqI polymorphism within the c-Ha-ras-1 VTR is associated with melanoma. ( 2572539 )
1989
102
TaqI polymorphism in the LDL receptor gene and a TaqI 1.5-kb band associated with familial hypercholesterolemia. ( 2901393 )
1988
103
A TaqI polymorphism at human homeo box gene locus on chromosome 12. ( 2905052 )
1988
104
A new TaqI polymorphism of the complement factor B gene. ( 2905448 )
1988
105
Presence of a TaqI polymorphism in the human glutamate dehydrogenase (GLUD) gene on chromosome 10. ( 2888080 )
1987
106
TaqI polymorphism in the human LDL receptor gene. ( 2889198 )
1987
107
A new TaqI polymorphism detected by the cDNA encoding amyloid beta protein of Alzheimer's disease. ( 2891111 )
1987
108
TaqI polymorphism at the 3' end of the human pronatriodilatin gene (hPND). ( 2878413 )
1986
109
TaqI polymorphism at the human coagulation factor XII locus (F12). ( 3014444 )
1986
110
pG95 alpha 1-7dIII/RI, a single copy clone at Xp11.4 which recognises a TaqI polymorphism (DXS209). ( 3024116 )
1986
111
p49f, A highly polymorphic probe, that detects Taq1 RFLPs on the human Y chromosome. ( 2999718 )
1985

Variations for Taqi Polymorphism

Expression for Taqi Polymorphism

Search GEO for disease gene expression data for Taqi Polymorphism.

Pathways for Taqi Polymorphism

Pathways related to Taqi Polymorphism according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1 10.21 CCNA2 VDR

GO Terms for Taqi Polymorphism

Cellular components related to Taqi Polymorphism according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.43 ACTA2 FGA IL12B INHBA REN TGFA
2 receptor complex GO:0043235 8.8 IL12B LDLR VDR

Biological processes related to Taqi Polymorphism according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.56 ACTA2 INHBA LDLR VDR
2 response to drug GO:0042493 9.46 DRD2 INHBA REN TGFA
3 long-term memory GO:0007616 9.32 DRD2 LDLR
4 drinking behavior GO:0042756 8.96 DRD2 REN
5 regulation of MAPK cascade GO:0043408 8.8 DRD2 INHBA REN

Molecular functions related to Taqi Polymorphism according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 growth factor activity GO:0008083 9.13 IL12B INHBA TGFA
2 signaling receptor binding GO:0005102 8.92 DRD2 FGA INHBA REN

Sources for Taqi Polymorphism

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....